Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014

Eurosurveillance

Volumn 19, Issue 9, 2014, Pages

  McNeil, S A ^a   Shinde, V ^b   Andrew, M ^a   Hatchette, T F ^a   Leblanc, J ^a   Ambrose, A ^a   Boivin, G ^c   Bowie, W R ^d   Diaz Mitoma, F ^e   ElSherif, M ^a   Green, K ^f   Haguinet, F ^b   Halperin, S ^a   Ibarguchi, B ^g   Katz, K ^h   Langley, J M ^a   Lagaca Wiens P ⁱ   Light, B ⁱ   Loeb, M ^j   McElhaney, J ^e   MacKinnon Cameron, D ^a   McCarthy, A E ^k   Poirier, M ^l   Powis, J ^m   Richardson, D ⁿ   Semret, M ^o   Smith, S ^p   Smyth, D ^q   Stiver, G ^d   Trottier, S ^c   Valiquette, L ^r   Webster, D ^s   Ye, L ^a   McGeer, A ^f   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Advanced Medical Research Institute of Canada   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

^g GLAXOSMITHKLINE   (Canada)

^h NORTH YORK GENERAL HOSPITAL   (Canada)

ⁱ ST BONIFACE GENERAL HOSPITAL   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k UNIVERSITY OF OTTAWA   (Canada)

^l Agence de Santé et des Services Sociaux Mauricie Centre du Québec in Trois Rivieres   (Canada)

^m TORONTO EAST GENERAL HOSPITAL   (Canada)

ⁿ William Osler Health Centre   (Canada)

^o MCGILL UNIVERSITY   (Canada)

^p UNIVERSITY OF ALBERTA   (Canada)

^q MONCTON HOSPITAL   (Canada)

^r UNIVERSITÉ DE SHERBROOKE   (Canada)

^s Horizon Health   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANADA; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; CANADA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LABORATORIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SEASONS; SENTINEL SURVEILLANCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84896901087     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.9.20729     Document Type: Article

References (18)

1. National Advisory Committee on Immunization. Statement on Seasonal Influenza Vaccine for 2013-2014. Canada communicable disease report. 2013;39(ACS-4):1-37. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/13vol39/acs-dcc-4/index-eng.php
2. Public Health Agency of Canada. FluWatch report: February 2 to 8, 2014 (Week 06) FluWatch 2014:6. Available from: http://www.phac-aspc.gc.ca/fluwatch/13-14/w06_14/index-eng.php
3. Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ. 2010;182(18):1981-7. http://dx.doi.org/10.1503/cmaj.100746
4. van't Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, van den Wijngaard CC, et al. Surveillance of Hospitalisations for 2009 Pandemic Influenza A(H1N1) in the Netherlands, 5 June-31 December 2009. Euro Surveill. 2010;15(2):pii=19461.
5. Campbell CN, Mytton OT, McLean EM, Rutter PD, Peabody RG, Sachedina N, et al. Hospitalisation in two waves of pandemic influenza A (H1N1) in England. Epidemiol Infect. 2011;139(10):1560-9. http://dx.doi.org/10.1017/S0950268810002657
6. Bandaranayake D, Jacobs M, Baker M, Hunt D, Wood T, Bissielo A, et al. The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill. 2011;16(6):pii=19788.
7. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-44. http://dx.doi.org/10.1056/NEJMoa0906695
8. Bramley, Dasgupta S, Skarbinski J, Kamimoto L, Fry AM, Finelli L, et al. Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection-United States, 2009. Influenza Other Respir Viruses. 2012;6(6):e134-42. http://dx.doi.org/10.1111/j.1750-2659.2012.00385.x
9. Dao CN, Kamimoto L, Nowell M, Reingold A, Gershman K, Meek J, et al. Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States. J Infect Dis. 2010;202(6):881-8. http://dx.doi.org/10.1086/655904
10. Chaves SS, Aragon D, Bennett N, Cooper T, D'Mello T, Farley M, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: Exploring disease severity by virus type and subtype. J Infect Dis. 2013;208(8):1305-14. http://dx.doi.org/10.1093/infdis/jit316
11. Cheng AC, Holmes M, Irving LB, Brown SG, Waterer GW, Korman TM, et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PloS One. 2013;8(7):e68760. http://dx.doi.org/10.1371/journal.pone.0068760
12. Delgado-Rodriguez M, Castilla J, Godoy P, Martin V, Soldevila N, Alonso J, et al. Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009-2010 in Spain. Influenza Other Respir Viruses. 2013;7(6):1336-42. http://dx.doi.org/10.1111/irv.12119
13. Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness-United States, february 2014. MMWR Morb Mortal Wkly Rep. 2014;63(7):137-42.
14. Skowronski D, Chambers C, Sabaiduc S, De Serres G, Dickinson J, Winter A, et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. Euro Surveill. 2014;19(5):pii=20690. http://dx.doi.org/10.2807/1560-7917.ES2014.19.5.20690
15. Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-12 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis. 2014; Jan 19. [Epub ahead of print]. http://dx.doi.org/10.1093/infdis/jiu048
16. Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill. 2014;19(6):pii=20700. http://dx.doi.org/10.2807/1560-7917.ES2014.19.6.20700
17. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013;31(17):2165-8. http://dx.doi.org/10.1016/j.vaccine.2013.02.053
18. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014;19(6):pii=20701. http://dx.doi.org/10.2807/1560-7917.ES2014.19.6.20701